Identification of circulating microRNAs in HNF1A-MODY carriers

Diabetologia

Volumn 56, Issue 8, 2013, Pages 1743-1751

  Bonner, C ^a,b   Nyhan, K C ^a,c   Bacon, S ^c   Kyithar, M P ^c   Schmid, J ^a   Concannon, C G ^a   Bray, I M ^a,d   Stallings, R L ^a,d   Prehn, J H M ^a   Byrne, M M ^c  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b France   (France)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

Beta cell; HNF1A MODY; microRNA; TCF 1

Indexed keywords

HEMOGLOBIN A1C; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; MICRORNA; MICRORNA 103; MICRORNA 224; MICRORNA 292 3P; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; CELL LINE; CELL STRAIN INS 1; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY; FEMALE; FRAMESHIFT MUTATION; GENE EXPRESSION; HEPATOCYTE NUCLEAR FACTOR 1ALPHA NON INSULIN DEPENDENT DIABETES MELLITUS; HETEROZYGOTE; HNF1A GENE; HUMAN; IN VITRO STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; DIABETES MELLITUS, TYPE 2; FRAMESHIFT MUTATION; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; INSULINOMA; MICRORNAS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; T CELL TRANSCRIPTION FACTOR 1;

EID: 84879909809     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2939-4     Document Type: Article

References (46)

1. Bell GI, Polonsky KS (2001) Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414:788-791
2. Kaisaki PJ, Menzel S, Lindner T et al (1997) Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 46:528-535
3. Wang H, Antinozzi PA, Hagenfeldt KA, Maechler P, Wollheim CB (2000) Molecular targets of a human HNF1 alpha mutation responsible for pancreatic beta-cell dysfunction. EMBO J 19:4257-4264
4. Yamagata K, Furuta H, Oda N et al (1996) Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 384:458-460
5. Boutin P, Chevre JC, Hani EH et al (1997) An automated fluorescent single-strand conformation polymorphism technique for screening mutations in the hepatocyte nuclear factor-1alpha gene (maturity-onset diabetes of the young). Diabetes 46:2108-2109
6. Servitja JM, Pignatelli M, Maestro MA et al (2009) Hnf1alpha (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver. Mol Cell Biol 29:2945-2959
7. Yamagata K, Nammo T, Moriwaki M et al (2002) Overexpression of dominant-negative mutant hepatocyte nuclear factor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes. Diabetes 51:114-123
8. Bonner C, Bacon S, Concannon CG et al (2010) INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells. Diabetes 59:2799-2808
9. Bonner C, Farrelly AM, Concannon CG et al (2011) Bone morphogenetic protein 3 controls insulin gene expression and is down-regulated in INS-1 cells inducibly expressing a hepatocyte nuclear factor 1A-maturity-onset diabetes of the young mutation. J Biol Chem 286:25719-25728
10. Wang H, Maechler P, Hagenfeldt KA, Wollheim CB (1998) Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line. EMBO J 17:6701-6713
11. Nammo T, Yamagata K, Hamaoka R et al (2002) Expression profile of MODY3/HNF-1alpha protein in the developing mouse pancreas. Diabetologia 45:1142-1153
12. Calin GA, Croce CM (2006) MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25:6202-6210
13. Poy MN, Eliasson L, Krutzfeldt J et al (2004) A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432:226-230
14. Trajkovski M, Hausser J, Soutschek J et al (2011) MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474:649-653
15. Poy MN, Spranger M, Stoffel M (2007) microRNAs and the regulation of glucose and lipid metabolism. Diabetes Obes Metab 9(Suppl 2):67-73
16. Guo G, Wang W, Bradley A (2004) Mismatch repair genes identified using genetic screens in Blm-deficient embryonic stem cells. Nature 429:891-895
17. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
18. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH (2007) Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol 5:e203
19. Baroukh N, Ravier MA, Loder MK et al (2007) MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem 282:19575-19588
20. Wobser H, Dussmann H, Kogel D et al (2002) Dominant-negative suppression of HNF-1 alpha results in mitochondrial dysfunction, INS-1 cell apoptosis, and increased sensitivity to ceramide-, but not to high glucose-induced cell death. J Biol Chem 277:6413-6421
21. Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB (1992) Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:167-178
22. da Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57
23. Dennis G Jr, Sherman BT, Hosack DA et al (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4:P3
24. Kyithar MP, Bacon S, Pannu KK et al (2011) Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications. Diabetes Metab 37:512-519
25. Ellard S, Colclough K (2006) Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Hum Mutat 27:854-869
26. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ (2001) A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24:539-548
27. Kozomara A, Griffiths-Jones S (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152-D157
28. Kajimoto K, Naraba H, Iwai N (2006) MicroRNA and 3T3-L1 pre-adipocyte differentiation. RNA 12:1626-1632
29. Herrera BM, Lockstone HE, Taylor JM et al (2010) Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 53:1099-1109
30. Mees ST, Mardin WA, Sielker S et al (2009) Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol 16:2339-2350
31. Wang Y, Toh HC, Chow P et al (2012) MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms. FASEB J 26:3032-3041
32. Lichner Z, Mejia-Guerrero S, Ignacak M et al (2012) Pleiotropic action of renal cell carcinoma-dysregulated miRNAs on hypoxia-related signaling pathways. Am J Pathol 180:1675-1687
33. Jeannot E, Mellottee L, Bioulac-Sage P et al (2010) Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage. Diabetes 59:1836-1844
34. Rebouissou S, Vasiliu V, Thomas C et al (2005) Germline hepatocyte nuclear factor 1alpha and 1beta mutations in renal cell carcinomas. Hum Mol Genet 14:603-614
35. Laurent-Puig P, Plomteux O, Bluteau O et al (2003) Frequent mutations of hepatocyte nuclear factor 1 in colorectal cancer with microsatellite instability. Gastroenterology 124:1311-1314
36. Lazarevich NL, Cheremnova OA, Varga EV et al (2004) Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors. Hepatology 39:1038-1047
37. Yao G, Yin M, Lian J et al (2010) MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol 24:540-551
38. Zampetaki A, Kiechl S, Drozdov I et al (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107:810-817
39. Nielsen LB, Wang C, Sorensen K et al (2012) Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression. Exp Diabetes Res 2012:896362
40. McDonald TJ, Shields BM, Lawry J et al (2011) High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care 34:1860-1862
41. Thanabalasingham G, Huffman JE, Kattla JJ et al (2013) Mutations in HNF1A result in marked alterations of plasma glycan profile. Diabetes 62:1329-1337
42. Mitchell PS, Parkin RK, Kroh EM et al (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513-10518
43. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654-659
44. Hunter MP, Ismail N, Zhang X et al (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3:e3694
45. Wang K, Zhang S, Weber J, Baxter D, Galas DJ (2010) Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 38:7248-7259
46. Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39:7223-7233